The DASH Diet Lowered Blood Pressure 11 Points in Landmark Trial

The DASH trials are unusually useful because researchers supplied the food, controlled key exposures and measured blood pressure. The household version is less controlled: portions, packaged foods and adherence vary. The central task is therefore to understand what was compared before turning an 11-point headline into an expectation. This article distinguishes the original dietary-pattern trial from the later sodium trial, then separates their measured effects from the practical choices a reader might discuss with a clinician or dietitian.

Audit the pantry before counting an expected pressure drop

Choose one ordinary day of eating and sort its foods into the actual DASH categories. Check the labels on bread, sauces, soups and other packaged items rather than counting only salt added at the table. Identify a substitution that preserves the meal's usefulness and affordability. A blood-pressure record can accompany that discussion, but should not be used to stop or adjust medication independently. The feeding trials estimate a contrast between assigned diets, not a guaranteed response to any single household swap. Their serving tables are separate guides and need their own calorie context.

The original 1997 trial

Lawrence Appel of Johns Hopkins and colleagues enrolled 459 adults with systolic pressures below 160 and diastolic pressures between 80 and 95 millimeters of mercury. For three weeks everyone ate a control diet low in fruits, vegetables, and dairy. Participants were then randomized for eight weeks to continue the control diet, eat a fruits-and-vegetables diet, or eat the combination diet that became known as DASH. Sodium intake and body weight were held constant, so any blood pressure change could be attributed to the diet's structure.

The combination diet reduced systolic pressure by 5.5 and diastolic pressure by 3.0 millimeters of mercury more than the control diet. The fruits-and-vegetables diet produced a smaller 2.8-millimeter systolic reduction, evidence that the full pattern, not produce alone, does the work.

Who gained the most

The 1997 trial's most consequential finding was the stratification. Among the 133 participants with hypertension, the DASH diet lowered systolic pressure by 11.4 and diastolic pressure by 5.5 millimeters more than control. Among the 326 participants without hypertension, the corresponding reductions were 3.5 and 2.1.

In other words, the diet behaved like a graded antihypertensive agent: modest in people with normal blood pressure, substantial in those with elevated readings. Subgroup work on participants with isolated systolic hypertension found even larger systolic reductions, above 11 millimeters.

The DASH-Sodium trial of 2001

The second landmark study, led by Frank Sacks and colleagues, asked whether sodium reduction and the DASH diet added to each other. It enrolled 412 adults and assigned each to either the DASH diet or a typical American control diet. Within each diet arm, participants ate food prepared at high, intermediate, and low sodium levels, roughly 3,450, 2,300, and 1,150 milligrams of sodium per day, for 30 consecutive days each in random order.

The interventions proved independent and additive. Compared with the control diet at high sodium, the DASH diet at low sodium lowered systolic pressure by 11.5 millimeters of mercury in participants with hypertension and by 7.1 in those without. Reducing sodium helped at every level, and the DASH diet helped at every sodium level.

Later analyses sharpened the picture

A 2017 reanalysis by Stephen Juraschek and colleagues in the Journal of the American College of Cardiology stratified the DASH-Sodium results by baseline blood pressure. The combined regimen of low sodium plus DASH versus high sodium plus control lowered systolic pressure by 5.3 millimeters at the lowest baseline stratum and by 20.8 millimeters at the highest, in participants starting at or above 150 millimeters.

That gradient matters clinically: the people with the most to lose from hypertension saw the largest reductions.

Why the diet works

DASH delivers large amounts of potassium, magnesium, calcium, and fiber while restricting saturated fat, and those components plausibly act on vascular tone and fluid balance in complementary ways. Sodium reduction works through a separate pathway, which is why the two effects add rather than overlap.

The feeding-study design is worth dwelling on because it is almost never repeated. In daily life, nutrition research must trust participants to eat what they say, and measurement error blurs every comparison. The DASH trials instead prepared every meal, weighed every portion, and held body weight constant, converting diet from the noisiest variable in medicine into a controlled exposure. That is why guideline committees have treated the blood pressure effect as established fact rather than a promising association.

Because participants were fed prepared meals, the trials measured the diet's potential, not real-world adherence. The eight-week trials also enrolled people with prehypertension or stage 1 hypertension, so results do not extend to severe hypertension, and no trial tested the diet as a replacement for medication.

What the pattern looks like on a plate

For a 2,000-calorie example, NHLBI lists 6 to 8 daily servings of grains, 4 to 5 each of vegetables and fruit, and 2 to 3 of low-fat dairy. Meat, poultry and fish have their own allowance of 6 or fewer one-ounce servings; nuts, seeds and legumes have a weekly allowance. These categories should not be combined into a single six-serving limit. Household substitutions can move a diet toward DASH, but using herbs instead of salt does not recreate the sodium-controlled feeding trial. Total intake still depends on packaged foods, portions and everything else eaten.

The legacy

The trials' design remains their quiet achievement: controlled feeding, constant weight, and randomization removed almost every alternative explanation. The diet has appeared in United States and international hypertension guidelines ever since, and later network meta-analyses of non-drug interventions ranked it among the most effective lifestyle treatments for elevated blood pressure.

Translating the trials to a home kitchen remains the harder step. The research diets specified daily servings of fruits, vegetables, low-fat dairy, and lean protein while limiting sweets and saturated fat, and later implementation studies have tested meal plans, counseling, and grocery-based versions of the pattern. Effects in free-living settings tend to run smaller than in the feeding trials as adherence slips, but the direction is consistent: the closer people get to the pattern, the more of the blood pressure benefit they keep.

For anyone taking blood pressure medication, the evidence supports the DASH pattern as an addition to treatment, not a substitute, and changes to diet or sodium intake should be discussed with a clinician who can monitor the response.